Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Shun-Ichiro Ota"'
Autor:
Yusuke Kashiwado, Chikako Kiyohara, Yasutaka Kimoto, Shuji Nagano, Takuya Sawabe, Kensuke Oryoji, Shinichi Mizuki, Hiroaki Nishizaka, Seiji Yoshizawa, Shigeru Yoshizawa, Tomomi Tsuru, Yasushi Inoue, Naoyasu Ueda, Shun-ichiro Ota, Yasuo Suenaga, Tomoya Miyamura, Yoshifumi Tada, Hiroaki Niiro, Koichi Akashi, Takahiko Horiuchi
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-9 (2022)
Abstract Background To analyse the subsequent clinical course of patients with rheumatoid arthritis (RA) who either continued or discontinued biologic agents after hospitalization for infections. Methods We retrospectively reviewed the clinical recor
Externí odkaz:
https://doaj.org/article/092362ecdaab40f0b3faa7e9100fe8c8
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background Pepsin agglutinators, discovered over 50 years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope. AHAs have different reactivity for each hinge epitope generat
Externí odkaz:
https://doaj.org/article/370c242bec31491eac23aa0183ad62bd
Autor:
Shinichi Mizuki, Tomomi Tsuru, Yasutaka Kimoto, Shun-ichiro Ota, Shigeru Yoshizawa, Hiroaki Niiro, Kensuke Oryoji, Shuji Nagano, Yasuo Suenaga, Seiji Yoshizawa, Yoshifumi Tada, Takuya Sawabe, Koichi Akashi, Tomoya Miyamura, Naoyasu Ueda, Yasushi Inoue, Chikako Kiyohara, Takahiko Horiuchi, Hiroaki Nishizaka, Yusuke Kashiwado
Publikováno v:
Arthritis researchtherapy. 24(1)
Background To analyse the subsequent clinical course of patients with rheumatoid arthritis (RA) who either continued or discontinued biologic agents after hospitalization for infections. Methods We retrospectively reviewed the clinical records of 230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69942bdde6c4a430c2b844080796eefc
https://pubmed.ncbi.nlm.nih.gov/35650638
https://pubmed.ncbi.nlm.nih.gov/35650638
Autor:
Yukiko Takeyama, Shuji Nagano, Takuya Sawabe, Nobuyuki Ono, Kensuke Oryoji, Yasutaka Kimoto, Tomoya Miyamura, Hisako Inoue, Naoyasu Ueda, Katsuhisa Miyake, Hitoshi Nakashima, Hiroaki Niiro, Yoshifumi Tada, Shun Ichiro Ota, Ayako Takamori, Yasushi Inoue, Seiji Yoshizawa, Takahiko Horiuchi, Yuri Sadanaga
Publikováno v:
The Journal of Rheumatology. 48:417-425
Objective.We investigated the association of airway comorbidities with the clinical phenotypes and outcomes of myeloperoxidase (MPO)–antineutrophil cytoplasmic antibodies (ANCA)–positive ANCA-associated vasculitis (AAV).Methods.An AAV patient mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fb7319b516e51b32e95fe18125f3a9
https://doi.org/10.3899/jrheum.190373
https://doi.org/10.3899/jrheum.190373
Autor:
Kensuke Oryoji, Hiroki Mitoma, Yuri Shirahama, Takuya Sawabe, Naoya Nishimura, Naoyasu Ueda, Hiroaki Niiro, Naoko Himuro, Yasushi Inoue, Akihito Maruyama, Yasutaka Kimoto, Takahiko Horiuchi, Katsuhisa Miyake, Atsushi Tanaka, Ayumi Uchino, Shuji Nagano, Hisako Inoue, Yoshifumi Tada, Seiji Yoshizawa, Nobuyuki Ono, Tomoya Miyamura, Yukiko Takeyama, Ayako Takamori, Shun Ichiro Ota
Publikováno v:
Modern rheumatology. 31(2)
We examined the efficacy and safety of rituximab (RTX) maintenance therapy for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan.We conducted a retrospective study using a multi-center cohort database of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d031ee6a8b2adc96350e393bf94f623
https://pubmed.ncbi.nlm.nih.gov/32615836
https://pubmed.ncbi.nlm.nih.gov/32615836
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Background Pepsin agglutinators, discovered over 50 years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope. AHAs have different reactivity for each hinge epitope generated by eac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7858eecab723993505c749425d302112
https://doi.org/10.1186/s13075-020-02251-7
https://doi.org/10.1186/s13075-020-02251-7
Background. Pepsin agglutinators, discovered over 50 years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope. AHAs have different reactivity for each hinge epitope generated by ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b47b7e54d105affa93af0529e5aee7
https://doi.org/10.21203/rs.2.21747/v3
https://doi.org/10.21203/rs.2.21747/v3
Background The pepsin agglutinator, discovered over 50 years ago, has recently referred to be an anti-hinge antibody (AHA) because of main reacting with the IgG hinge epitope. AHA shows different reactivity for each hinge epitope generated by each pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0883c812146e9eb8784d57872c3f481
https://doi.org/10.21203/rs.2.21747/v1
https://doi.org/10.21203/rs.2.21747/v1
Autor:
Hiroshi Ariyama, Kyoko Yamaguchi, Mamoru Ito, Shun Ichiro Ota, Hiroaki Niiro, Hitoshi Kusaba, Michitaka Nakano, Fumiyasu Hanamura, Naoko Wada, Hirofumi Ohmura, Koji Mishima, Kenji Tsuchihashi, Hiroshi Uchi, Eishi Baba, Koichi Akashi
Publikováno v:
Cancer Science
Human anti-programmed death-1 (PD-1) antibody possesses the capability to revitalize host T cells and has been an effective therapy for metastatic malignant melanoma (MM). The precise subsets of T cells predominantly activated by anti-PD-1, however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccbb91dfc2fe0884d60d12b6904a1ce
https://doi.org/10.1111/cas.13758
https://doi.org/10.1111/cas.13758
Autor:
Nobuyuki Ono, Yasushi Inoue, Tomoya Miyamura, Naoyasu Ueda, Shuji Nagano, Hisako Inoue, Kensuke Oryoji, Shun-ichiro Ota, Takuya Sawabe, Seiji Yoshizawa, Yukiko Takeyama, Yuri Sadanaga, Ayako Takamori, Yasutaka Kimoto, Katsuhisa Miyake, Takahiko Horiuchi, Hitoshi Nakashima, Hiroaki Niiro, Yoshifumi Tada, Ono, Nobuyuki
Publikováno v:
Journal of Rheumatology; Mar2021, Vol. 48 Issue 3, p417-425, 9p